Status:
COMPLETED
Antiseptic Mouth Rinses to Reduce Salivary Viral Load in COVID-19 Patients
Lead Sponsor:
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Collaborating Sponsors:
Hospital Universitario Fundación Jiménez Díaz
Hospital Universitario General de Villalba
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
As no curative treatment for SARS-CoV-2 is currently available, most public health measures to contain the pandemic are based on preventing the spread of the pathogen. The virus is transmitted by the ...
Detailed Description
Strategies reducing salivary viral load could contribute to reduce the risk of transmission of SARS-CoV-2. Thus, the use of mouthwashes with antiseptics that have virucidal activity can be a simple an...
Eligibility Criteria
Inclusion
- Lower than 7 days from the positive SARS-COV-2 PCR test of a nasopharyngeal sample
- Have the ability to donate saliva samples and perform mouthwash
Exclusion
- Patient participation in a COVID-19 research study using experimental drugs,
- Use of an antiseptic mouthwash for 48 h before the start of the study
- Any known hypersensitivity or allergy to components of the mouthwashes.
Key Trial Info
Start Date :
June 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04707742
Start Date
June 15 2020
End Date
September 30 2021
Last Update
October 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alejandro Mira
Valencia, Spain, 46020